G-protein-coupled receptor kinase expression in hypertension

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 5, 1999, Pages 545-551

  Gros, Robert ^a,b   Tan, Christopher ^a,b   Chorazyczewski, Jozef ^a,b   Kelvin, David J ^a,b   Benovic, Jeffrey L ^a,b   Feldman, Ross D ^a,b,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERTENSION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSLATION REGULATION; VASODILATATION;

ADULT; BETA-ADRENERGIC RECEPTOR KINASE; BLOOD PRESSURE; BLOTTING, NORTHERN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; LYMPHOCYTES; MALE;

EID: 0032940662     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70074-3     Document Type: Article

References (25)

1. 1. Brodde OE, Martin MC. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertension 1992;10(suppl 7):S133-45.
2. 2. Lograno MD, Daniele E, Galli C. Changes of vascular smooth muscle reactivity in hypertensive rats. Pharmacol Res 1989;21:719-28.
3. 3. Sim MK, Chua ME. Altered responsiveness of the aorta of hypertensive rats to histamine and acetylcholine. Jpn J Pharmacol 1985;39:551-3.
4. 4. Suzuki H, Zweifach BW, Schmid-Schönbein GW. Vasodilator response of mesenteric arterioles to histamine in spontaneously hypertensive rats. Hypertension 1995;26:397-406.
5. 5. Kamikawa Y, Cline Jr WH, Su C. Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol 1980;66:347-53.
6. 6. Takase H, Dohi Y, Kojima M, Sato K. Changes in the endothelial cyclooxygenase pathway in resistance arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1994;23:326-30.
7. 7. Feldman RD, Gros R. Impaired vasodilator function in hypertension: the role of alterations in receptor/G-protein coupling. Trends Cardiovasc Med 1998;8:297-305.
8. 8. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990;85:647-52.
9. 9. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther 1990;48:87-95.
10. 1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats. Am J Physiol 1993;264(Regulatory Integrative Comp Physiol 33):R726-32.
11. 11. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989;84:1849-56.
12. 12. Anand-Srivastava MB. Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously hypertensive rats. Biochem Pharmacol 1988;37:3017-22.
13. 13. Bhalla RC, Ashley T. Altered function of adenylate cyclase in the myocardium of the spontaneously hypertensive rat. Biochem Pharmacol 1978;27:1967-71.
14. 14. Trinder D, Phillips PA, Risvanis J, Stephenson JM, Johnston CI. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension 1992;20:569-74.
15. 2-, and β-adrenergic receptors and their signalling. Hypertension 1993;22:169-77.
16. 16. Feldman R, Limbird LE, Nadeau J, Robertson D, Wood AJJ. Leukocyte β-receptor alterations in hypertensive subjects. J Clin Invest 1984;73:648-53.
17. 17. Feldman RD, Lawton WJ, McArdle WL. A low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. J Clin Invest 1987;79:290-4.
18. 18. Feldman RD, Tan CM, Chorazycewski J. G-Protein alterations in hypertension and aging. Hypertension 1995;26:725-8.
19. 19. Gros R, Benovic JL, Tan C, Feldman RD. G-Protein coupled receptor-kinase activity is increased in hypertension. J Clin Invest 1997;99:2087-93.
20. 20. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J 1990;4:2881-9.
21. 21. Palezewski K, Benovic JL. G-Protein-coupled receptor kinases. Trends Biochem Sci 1991;16:387-91.
22. 22. Barnes PJ. State of the art: beta-adrenergic receptors and their regulation. Am J Resp Crit Care Med 1995;152: 838-60.
23. 23. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;21(suppl 97):77-89.
24. 24. Loudon RP, Perussia B, Benovic JL. Differentially regulated expression of the G protein-coupled receptor kinases, βARK and GRK6, during myelomonocytic cell development in vitro. Blood 1996;88:4547-57.
25. 25. Hancock AA, Bush EN, Stanisic D, Kynel JJ, Lin CT. Data normalization before statistical analysis: keeping the horse before the cart. Trends Pharmacol Sci 1988;9:29-32.